Cav3.1 was previously identified as a genetic modifier of epilepsy in Scn1a+/− mice, as genetic knockdown of the Cav3.1-encoding gene Cacna1g was reported to ameliorate spontaneous seizures and improve survival (Calhoun et al., 2017). This evidence concerns the gene SCN1A and epilepsy.